List of works - Dag Nyholm

A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1: 3 and 1: 1.7 in the Treatment of Cervical Dystonia: A Double-Blind, Randomized, Crossover Trial

scientific article published on 01 September 2015

A Treatment-Response Index From Wearable Sensors for Quantifying Parkinson's Disease Motor States

scientific article published on 27 November 2017

A computer vision framework for finger-tapping evaluation in Parkinson's disease

scientific article published on 25 November 2013

A home environment test battery for status assessment in patients with advanced Parkinson's disease.

scientific article published on 09 September 2009

A new computer method for assessing drawing impairment in Parkinson's disease.

scientific article published on 12 May 2010

A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.

scientific article published on 26 December 2017

A survey of lifestyle factors in dystonia

scientific article published on 06 October 2020

A web application for follow-up of results from a mobile device test battery for Parkinson's disease patients.

scientific article published on 26 August 2011

Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's Disease

scientific article

Automatic and objective assessment of alternating tapping performance in Parkinson's disease.

scientific article published on 09 December 2013

Clinical experience of dose conversion ratios between 2 botulinum toxin products in the treatment of cervical dystonia

scientific article published on 01 November 2012

Complexity of motor response to different doses of duodenal levodopa infusion in Parkinson disease

scientific article published on 01 January 2012

Continuous drug delivery in Parkinson's disease.

scientific article

Development of new levodopa treatment strategies in Parkinson's disease-from bedside to bench to bedside

scientific article

Duodopa® treatment for advanced Parkinson's disease: A review of efficacy and safety ⬇️

scientific article published on July 21, 2012

Evaluation of a sensor algorithm for motor state rating in Parkinson's disease

scientific article published on 26 March 2019

Evaluation of zero-echo-time attenuation correction for integrated PET/MR brain imaging-comparison to head atlas and Ge-transmission-based attenuation correction

article

Everyday Occupations and Other Factors in Relation to Mental Well-Being among Persons with Advanced Parkinson's Disease

scientific article published on 26 November 2019

Feasibility of spirography features for objective assessment of motor function in Parkinson's disease

scientific article published on 31 March 2017

First clinical experience with levodopa/carbidopa microtablets in Parkinson's disease.

scientific article published on 15 March 2017

Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers.

scientific article

Individual dose-response models for levodopa infusion dose optimization

scientific article published on 01 February 2018

Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry.

scientific article published on 25 January 2018

Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease.

scientific article published on 4 October 2017

Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease

scientific article published on 12 June 2012

Levodopa fractionation in Parkinson's disease

scientific article published in January 2014

Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial

scientific article published on 05 December 2011

Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience.

scientific article published on December 2016

Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.

scientific article published on 4 June 2016

Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study

scientific article published on 17 December 2016

Levodopa/carbidopa intestinal gel infusion long‐term therapy in advanced Parkinson’s disease ⬇️

scientific article published on February 23, 2012

Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment

scientific article published on 18 January 2017

Long-term 24-h levodopa/carbidopa gel infusion in Parkinson's disease

scientific article published on 28 April 2012

Motion Sensor-Based Assessment of Parkinson's Disease Motor Symptoms During Leg Agility Tests: Results From Levodopa Challenge

scientific article published on 08 February 2019

Motor fluctuations and Helicobacter pylori in Parkinson's disease

scientific article published on 4 September 2013

Outcome prediction of enteral levodopa/carbidopa infusion in advanced Parkinson's disease.

scientific article published on 30 May 2006

Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.

scientific article

Pharmacokinetics of levodopa/carbidopa microtablets versus levodopa/benserazide and levodopa/carbidopa in healthy volunteers

scientific article published on 01 May 2012

Population pharmacokinetics of levodopa gel infusion in Parkinson's disease: effects of entacapone infusion and genetic polymorphism

scientific article published on 22 October 2020

Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson's disease patients

scientific article published on 07 June 2018

Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease

scientific article published on 28 November 2020

Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experience

scientific article published on 18 January 2019

Soft tissue-anchored transcutaneous port attached to an intestinal tube for long-term gastroduodenal infusion of levodopa/carbidopa in Parkinson disease.

scientific article published on 11 February 2009

Spiral drawing during self-rated dyskinesia is more impaired than during self-rated Off.

scientific article published on 9 February 2013

Stalevo reduction in dyskinesia evaluation in Parkinson's disease results were expected from a pharmacokinetic viewpoint

scientific article published on 01 February 2011

Stochastic anomaly detection in eye-tracking data for quantification of motor symptoms in Parkinson's disease.

scientific article

The effect of continuous levodopa treatment during the afternoon hours

scientific article published on 24 September 2018

Transcutaneous port for levodopa/carbidopa intestinal gel administration in Parkinson's disease.

scientific article published on 24 July 2015

Treatment of advanced Parkinson's disease with levodopa/carbidopa intestinal gel is associated with improvements in Hoehn and Yahr stage

scientific article published on 23 December 2011

Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders

scientific article published on 15 January 2015

Validation of a home environment test battery for supporting assessments in advanced Parkinson's disease.

scientific article published on 9 November 2011

Validation of parametric methods for [¹¹C]PE2I positron emission tomography

scientific article

Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease

scientific article published on 13 August 2015

Verification of a Method for Measuring Parkinson's Disease Related Temporal Irregularity in Spiral Drawings

scientific article

Workforce participation and activities in Parkinson's disease patients receiving device-aided therapy.

scientific article published on 22 March 2018

List of works by Dag Nyholm

A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1: 3 and 1: 1.7 in the Treatment of Cervical Dystonia: A Double-Blind, Randomized, Crossover Trial

A Treatment-Response Index From Wearable Sensors for Quantifying Parkinson's Disease Motor States

A computer vision framework for finger-tapping evaluation in Parkinson's disease

A home environment test battery for status assessment in patients with advanced Parkinson's disease.

A new computer method for assessing drawing impairment in Parkinson's disease.

A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.

A survey of lifestyle factors in dystonia

A web application for follow-up of results from a mobile device test battery for Parkinson's disease patients.

Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's Disease

Automatic and objective assessment of alternating tapping performance in Parkinson's disease.

Clinical experience of dose conversion ratios between 2 botulinum toxin products in the treatment of cervical dystonia

Complexity of motor response to different doses of duodenal levodopa infusion in Parkinson disease

Continuous drug delivery in Parkinson's disease.

Development of new levodopa treatment strategies in Parkinson's disease-from bedside to bench to bedside

Duodopa® treatment for advanced Parkinson's disease: A review of efficacy and safety ⬇️

Evaluation of a sensor algorithm for motor state rating in Parkinson's disease

Evaluation of zero-echo-time attenuation correction for integrated PET/MR brain imaging-comparison to head atlas and Ge-transmission-based attenuation correction

Everyday Occupations and Other Factors in Relation to Mental Well-Being among Persons with Advanced Parkinson's Disease

Feasibility of spirography features for objective assessment of motor function in Parkinson's disease

First clinical experience with levodopa/carbidopa microtablets in Parkinson's disease.

Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers.

Individual dose-response models for levodopa infusion dose optimization

Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry.

Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease.

Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease

Levodopa fractionation in Parkinson's disease

Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial

Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience.

Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.

Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study

Levodopa/carbidopa intestinal gel infusion long‐term therapy in advanced Parkinson’s disease ⬇️

Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment

Long-term 24-h levodopa/carbidopa gel infusion in Parkinson's disease

Motion Sensor-Based Assessment of Parkinson's Disease Motor Symptoms During Leg Agility Tests: Results From Levodopa Challenge

Motor fluctuations and Helicobacter pylori in Parkinson's disease

Outcome prediction of enteral levodopa/carbidopa infusion in advanced Parkinson's disease.

Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.

Pharmacokinetics of levodopa/carbidopa microtablets versus levodopa/benserazide and levodopa/carbidopa in healthy volunteers

Population pharmacokinetics of levodopa gel infusion in Parkinson's disease: effects of entacapone infusion and genetic polymorphism

Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson's disease patients

Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease

Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experience

Soft tissue-anchored transcutaneous port attached to an intestinal tube for long-term gastroduodenal infusion of levodopa/carbidopa in Parkinson disease.

Spiral drawing during self-rated dyskinesia is more impaired than during self-rated Off.

Stalevo reduction in dyskinesia evaluation in Parkinson's disease results were expected from a pharmacokinetic viewpoint

Stochastic anomaly detection in eye-tracking data for quantification of motor symptoms in Parkinson's disease.

The effect of continuous levodopa treatment during the afternoon hours

Transcutaneous port for levodopa/carbidopa intestinal gel administration in Parkinson's disease.

Treatment of advanced Parkinson's disease with levodopa/carbidopa intestinal gel is associated with improvements in Hoehn and Yahr stage

Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders

Validation of a home environment test battery for supporting assessments in advanced Parkinson's disease.

Validation of parametric methods for [¹¹C]PE2I positron emission tomography

Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease

Verification of a Method for Measuring Parkinson's Disease Related Temporal Irregularity in Spiral Drawings

Workforce participation and activities in Parkinson's disease patients receiving device-aided therapy.